Compass therapeutics to participate in the jefferies global healthcare conference

Boston, may 30, 2024 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in a fireside chat at the jefferies global healthcare conference taking place in new york city, ny june 5 – 6, 2024.
CMPX Ratings Summary
CMPX Quant Ranking